HHS.gov @HHSGov
NEWS: HHS and the @DeptofDefense have announced an agreement with @Merck to support advanced development and large-scale manufacturing of the their investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical #COVID19. https://t.co/YtezV8sdKg — PolitiTweet.org